...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: This so called “Expert Market”

When are they are going to get us on the TSX or NAS? 
 Decade plus & here we sit , no chance to liquidate in all this time + like I said earlier this looks more like another Eversana type deal - how much more liquidation is coming  are way? Just kicking the can down the road? NR is lacking the most important of details & not sure what we will hear without another NR? 

Anybody pumped about this?

Also what's your take on the no partner on # 11 Tada? 

Share
New Message
Please login to post a reply